Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 132

Mitsui enters Arcadia in $30m series C

Arcadia, the operator of a clean energy-sourcing platform for domestic use, boosted its overall equity funding to more than $62m in a Mitsui USA-backed round.

Dec 11, 2019

Imperative Care impresses with $79m

Ascension Ventures was among the participants in the first close of neurovascular catheter developer Imperative Care's series C round, which it expects to close at $85m.

Dec 11, 2019

LandSpace embraces $71m

Space rocket producer LandSpace, a Tsinghua University spinout, has now raised about $200m in all from investors including Xidian University and 36kr Media.

Dec 11, 2019

Zentalis zips to $85m series C

Pharmaron-backed Zentalis Pharmaceuticals has now secured $147m altogether and will advance its breast cancer and solid tumour candidates through clinical trials.

Dec 10, 2019

Ribo rips into series C1 round

Legend Capital returned as the RNA drug developer secured $28.8m in a round co-led by Panlin Capital and Trinity Innovation Fund.

Dec 9, 2019

Nutriati heats up with series C funding

PLT Health Solutions and existing backer Tate & Lyle Ventures contributed to a $12.7m round for vegan ingredients supplier Nutriati to take its total funding to more than $22m.

Dec 9, 2019

Corporate venturing deal net: 2-6 December 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds

Dec 6, 2019

Roche polishes Black Diamond's $85m series C

The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.

Dec 6, 2019

Figure finds $103m in series C round

MUFG Innovation Partners contributed to a round that boosted the valuation of the blockchain-based lending platform to $1.2bn.

Dec 6, 2019

Roche polishes Black Diamond's $85m series C

The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.

Dec 6, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here